Arindel Maharaj, M.D., PH.D
Internal Medicine Physician in Miami, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
Arindel Maharaj, M.D., PH.D reported a CMS MIPS final score of 81.3/100 — below the 83.1 national average — and filed 8,331 Medicare Part D claims in 2023.
- 81.3/100
- MIPS score · -2 vs avg
- 8K
- Part D claims, 2023
- 67%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
Arindel Maharaj, M.D., PH.D's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
81 36th percentile higher than 36% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Arindel Maharaj, M.D., PH.D sits
This provider among internal medicine physician peers
Across the 36,260 internal medicine physician providers who report both Medicare Part D prescribing and a MIPS quality score, Arindel Maharaj, M.D., PH.D writes more Part D claims than 89% of them and scores higher on MIPS quality than 36% — placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one internal medicine physician peer from a representative sample of 60; the gold marker is Arindel Maharaj, M.D., PH.D. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Arindel Maharaj, M.D., PH.D practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Arindel Maharaj, M.D., PH.D?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Florida
How Internal Medicine Physician compares to other specialties among Florida providers
Largest specialties in Florida (% of in-state providers)
Internal Medicine Physician ranks #9 among Florida's specialties (2.4% of in-state providers)
Each bar is a specialty's share of the Florida provider total, by primary NUCC taxonomy. The highlighted bar is Internal Medicine Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance — MIPS
Arindel Maharaj, M.D., PH.D's 2023 MIPS final score plotted against the Internal Medicine Physician national average
- MIPS Final Score
- 81.3/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Internal Medicine Physician) — 81.3/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Internal Medicine Physician US NPIs
81.3/100 MIPS final score — 1.8 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Internal Medicine Physician. Quality dim: 78.5. Cost dim: 50.6.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Arindel Maharaj, M.D., PH.D appears in the CMS NPPES registry as a Internal Medicine Physician provider holding M.D., PH.D credentials at 900 NW 17TH ST, Miami, FL, 33136, with a listed phone of (305) 243-2020. NPI 1003142365 was issued on 10/21/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Maharaj most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 8,331 prescription claims written by this provider, covering 1,367 Medicare beneficiaries and totaling roughly $963K in drug spend, split 33% brand-name and 67% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.3/100 for the 2023 performance year (Quality 78.5, Cost 50.6), compared with the national average of 83.1.
Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1003142365 |
|---|---|
| Specialty | Internal Medicine Physician |
| Credentials | M.D., PH.D |
| Gender | Male |
| NPI Issued | 10/21/2009 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Arindel Maharaj, M.D., PH.D's current license status, disciplinary history, and board certifications with the Florida Board of Medicine in Florida before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Arindel Maharaj, M.D., PH.D bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Arindel Maharaj, M.D., PH.D. Source: openpaymentsdata.cms.gov.
Total received
$1.8K
Largest payer
Glaukos Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Florida FLDOH 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to Arindel Maharaj, M.D., PH.D. To verify Arindel Maharaj, M.D., PH.D's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
33% brand-name claims vs 67% generic, on 8,331 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 16,778
- Total Day Supply
- 488,633
- Brand vs Generic
- 33% brand / 67% generic
- Brand Drug Cost
- $696K
- Generic Drug Cost
- $267K
Patient Demographics
- Average Patient Age
- 75.9 years
- Avg HCC Risk Score
- 1.36
- Gender Split
- 55% female / 45% male
- Age Distribution
- <65: 70, 65-74: 514, 75-84: 558, 85+: 225
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Arindel Maharaj, M.D., PH.D prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
2,140 claims
- Dorzolamide-Timolol
Dorzolamide-Timolol
1,049 claims
- Brimonidine Tartrate
Brimonidine Tartrate
1,020 claims
- Timolol Maleate 682
Timolol Maleate
682 claims
- Prednisolone Acetate 490
Prednisolone Acetate
490 claims
- Pilocarpine Hcl 367
Pilocarpine Hcl
367 claims
- Dorzolamide Hcl 345
Dorzolamide Hcl
345 claims
- Vyzulta 317
Vyzulta
317 claims
| Drug | Claims |
|---|---|
| Latanoprost | 2,140 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 1,049 |
| Brimonidine Tartrate | 1,020 |
| Timolol Maleate | 682 |
| Prednisolone Acetate | 490 |
| Pilocarpine Hcl | 367 |
| Dorzolamide Hcl | 345 |
| Vyzulta Latanoprostene Bunod | 317 |
| Rhopressa Netarsudil Mesylate | 171 |
| Moxifloxacin Moxifloxacin Hcl | 168 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Internal Medicine Physician Overview
How Arindel Maharaj, M.D., PH.D fits within the Internal Medicine Physician landscape nationally.
Arindel Maharaj, M.D., PH.D's 8,331 claims are above the specialty average of 2,716.
Nearby Internal Medicine Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Maharaj.
Compare Internal Medicine Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Florida medical board — federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Internal Medicine Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Florida
Frequently Asked Questions
What is Arindel Maharaj, M.D., PH.D's specialty? ▼
How much does Arindel Maharaj, M.D., PH.D prescribe under Medicare Part D? ▼
What is Arindel Maharaj, M.D., PH.D's Medicare quality score? ▼
Where is Arindel Maharaj, M.D., PH.D located? ▼
What is Arindel Maharaj, M.D., PH.D's NPI number? ▼
Does Arindel Maharaj, M.D., PH.D prescribe more brand-name or generic drugs? ▼
How many Internal Medicine Physician providers are there in the US? ▼
What drugs does Arindel Maharaj, M.D., PH.D prescribe most often? ▼
Does Arindel Maharaj, M.D., PH.D accept Medicare? ▼
How can I verify Arindel Maharaj, M.D., PH.D's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology